fostemsavir
Selected indexed studies
- Fostemsavir. (, 2006) [PMID:39190733]
- Fostemsavir: a first-in-class HIV-1 attachment inhibitor. (Curr Opin HIV AIDS, 2022) [PMID:34871189]
- Fostemsavir for the treatment of HIV. (Expert Rev Anti Infect Ther, 2021) [PMID:33331202]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fostemsavir. (2006) pubmed
- Fostemsavir: a first-in-class HIV-1 attachment inhibitor. (2022) pubmed
- Fostemsavir for the treatment of HIV. (2021) pubmed
- Fostemsavir: First Approval. (2020) pubmed
- Fostemsavir for HIV-1 infection. (2022) pubmed
- Fostemsavir. (2012) pubmed
- Fostemsavir: a new CD4 attachment inhibitor. (2018) pubmed
- Fostemsavir resistance in clinical context: a narrative review. (2025) pubmed
- Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administration. (2023) pubmed
- Evaluating fostemsavir as a therapeutic option for patients with HIV. (2021) pubmed